KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio: 2011-2023

Historic Interest Coverage Ratio for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Dec 2023 value amounting to -2.18.

  • Supernus Pharmaceuticals' Interest Coverage Ratio fell 408.31% to -19.33 in Q2 2023 from the same period last year, while for Jun 2023 it was 3.56, marking a year-over-year increase of 6.79%. This contributed to the annual value of -2.18 for FY2023, which is 133.44% down from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Interest Coverage Ratio of -2.18 as of FY2023, which was down 133.44% from 6.52 recorded in FY2022.
  • Supernus Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 7.31 during FY2020, with a 5-year trough of -2.18 in FY2023.
  • Its 3-year average for Interest Coverage Ratio is 2.67, with a median of 3.67 in 2021.
  • In the last 5 years, Supernus Pharmaceuticals' Interest Coverage Ratio soared by 77.63% in 2022 and then tumbled by 133.44% in 2023.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Interest Coverage Ratio stood at 6.54 in 2019, then grew by 11.76% to 7.31 in 2020, then plummeted by 49.77% to 3.67 in 2021, then spiked by 77.63% to 6.52 in 2022, then tumbled by 133.44% to -2.18 in 2023.